Beijing Geekgene Technology Co., LTD: Clinical Trials

9 trials sponsored by Beijing Geekgene Technology Co., LTD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 recruiting, 3 not yet recruiting, 1 active not recruiting. 4 Early Phase 1, 4 Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 14Not yet recruiting 2, Recruiting 2
Phase 14Recruiting 2, Active not recruiting 1, Not yet recruiting 1

Follow Beijing Geekgene Technology Co., LTD: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Study GK01 Cell Injection in Subjects With Advanced Lung Cancer
GK01 Injection - Advanced Lung Cancer
Early Phase 1Not yet recruitingBeijing Geekgene Technology Co., LTD102026-07-012026-06-29
A Clinical Study GK01 Cell Injection in Subjects With Advanced Solid Tumors.
GK01 injection - Advanced Solid Tumors
Early Phase 1Not yet recruitingBeijing Geekgene Technology Co., LTD102026-06-012026-06-25
A Clinical Study GK01 Injection in Subjects With Advanced Malignant Solid Tumors
GK01 injection - Advanced Solid Tumors
Phase 1Not yet recruitingBeijing Geekgene Technology Co., LTD152026-04-012026-03-23
A Single-Arm, Open-Label Clinical Study GK01 Cell Injection in Subjects With Advanced Solid Tumors.
GK01 Injection - Advanced Solid Tumors
Early Phase 1RecruitingBeijing Geekgene Technology Co., LTD102026-02-132026-02-17
A Clinical Study to Evaluate GK01 Cell Injection in Combination With PD-1 Monoclonal Antibody for Advanced Solid Tumors
GK01 combination with PD-1 monoclonal antibody - Solid Tumors
Phase 1Active not recruitingTianjin Medical University Cancer Institute and Hospital152025-12-042026-02-12
A Single-arm, Open-label Study of GK01 in Combination With or Without Chemotherapy for the Adjuvant Treatment of Solid Tumors
GK01 Injection - Solid Tumors
Phase 1RecruitingTianjin Medical University Cancer Institute and Hospital152025-10-162026-01-20
A Clinical Study of GK02 in Malignant Ascites
GK02 - Malignant Ascites Caused by Advanced Solid Tumors
Early Phase 1RecruitingBeijing Geekgene Technology Co., LTD92025-09-162026-01-30
A Single-Arm, Open-Label, Phase I Study of GK01 for Advanced Solid Tumor
GK01 Injection - Advanced Solid Tumors
Phase 1RecruitingTianjin Medical University Cancer Institute and Hospital152025-03-182025-05-01
a Single-arm, Single-center, Open Clinical Study
TCR T-cells - Gastric Cancer, Esophageal Cancer
RecruitingBeijing Geekgene Technology Co., LTD102023-07-192024-05-28

Conditions studied

Stomach Neoplasms (2)  ·  Esophageal Neoplasms (1)  ·  Uterine Cervical Neoplasms (1)

Countries

China (9)

Top investigators

Jun Zhao, MD (1)  ·  Lin Shen (1)  ·  Lin Shen, MD,PhD (1)